Tue, Jul 29, 2014, 5:07 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

studythosestocks 1 post  |  Last Activity: May 8, 2014 11:21 PM Member since: Sep 29, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    From the MF article....

    by lifetolive7 May 8, 2014 7:25 AM
    studythosestocks studythosestocks May 8, 2014 11:21 PM Flag

    LTL7, remember that the reason Dacogen was rejected if not mistaken is that it was not appropriately powered statistically. This is the reason we will have 562 Events and that it was expanded 50% from the original 350 events originally planned. To me, the fact that the unblinding is being dragged out with no change in quality care of those taking Cytarabine speaks volumes. Been here a long time and post rarely now but still dive into the research when I have a chance. Don't trust the share price, it has been all over the place. I don't know which way the markets will go but it may be another 5 months before Valor is unblinded. With a major correction in the market, SNSS will follow the tide most likely until unblinded. One of the safer high risk plays currently out on the market IMO. Take care and good luck.

AMRN
1.57+0.03(+1.95%)Jul 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.